Ariel Pablos-Mendez, Sunil Chacko and Timothy Evans discuss the growing problem of market failures in the development of essential vaccines and drugs for orphan diseases, as well as the public-private mechanisms available to bring the opportunity of new science and technology to bear on diseases of the poor.
